Activation of the PIK3CA/AKT Pathway Suppresses Senescence Induced by an Activated RAS Oncogene to Promote Tumorigenesis

Mutations in both RAS and the PTEN/PIK3CA/AKT signaling module are found in the same human tumors. PIK3CA and AKT are downstream effectors of RAS, and the selective advantage conferred by mutation of two genes in the same pathway is unclear. Based on a comparative molecular analysis, we show that ac...

Full description

Bibliographic Details
Main Authors: Kennedy, A, Morton, J, Manoharan, I, Nelson, D, Jamieson, N, Pawlikowski, J, McBryan, T, Doyle, B, McKay, C, Oien, K, Enders, G, Zhang, R, Sansom, O, Adams, P
Format: Journal article
Language:English
Published: Elsevier 2011
_version_ 1797054489990004736
author Kennedy, A
Morton, J
Manoharan, I
Nelson, D
Jamieson, N
Pawlikowski, J
McBryan, T
Doyle, B
McKay, C
Oien, K
Enders, G
Zhang, R
Sansom, O
Adams, P
author_facet Kennedy, A
Morton, J
Manoharan, I
Nelson, D
Jamieson, N
Pawlikowski, J
McBryan, T
Doyle, B
McKay, C
Oien, K
Enders, G
Zhang, R
Sansom, O
Adams, P
author_sort Kennedy, A
collection OXFORD
description Mutations in both RAS and the PTEN/PIK3CA/AKT signaling module are found in the same human tumors. PIK3CA and AKT are downstream effectors of RAS, and the selective advantage conferred by mutation of two genes in the same pathway is unclear. Based on a comparative molecular analysis, we show that activated PIK3CA/AKT is a weaker inducer of senescence than is activated RAS. Moreover, concurrent activation of RAS and PIK3CA/AKT impairs RAS-induced senescence. In vivo, bypass of RAS-induced senescence by activated PIK3CA/AKT correlates with accelerated tumorigenesis. Thus, not all oncogenes are equally potent inducers of senescence, and, paradoxically, a weak inducer of senescence (PIK3CA/AKT) can be dominant over a strong inducer of senescence (RAS). For tumor growth, one selective advantage of concurrent mutation of RAS and PTEN/PIK3CA/AKT is suppression of RAS-induced senescence. Evidence is presented that this new understanding can be exploited in rational development and targeted application of prosenescence cancer therapies.
first_indexed 2024-03-06T18:57:58Z
format Journal article
id oxford-uuid:12829cd0-a1f0-4a4f-b471-0ec7737e0e9f
institution University of Oxford
language English
last_indexed 2024-03-06T18:57:58Z
publishDate 2011
publisher Elsevier
record_format dspace
spelling oxford-uuid:12829cd0-a1f0-4a4f-b471-0ec7737e0e9f2022-03-26T10:08:23ZActivation of the PIK3CA/AKT Pathway Suppresses Senescence Induced by an Activated RAS Oncogene to Promote TumorigenesisJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:12829cd0-a1f0-4a4f-b471-0ec7737e0e9fEnglishSymplectic Elements at OxfordElsevier2011Kennedy, AMorton, JManoharan, INelson, DJamieson, NPawlikowski, JMcBryan, TDoyle, BMcKay, COien, KEnders, GZhang, RSansom, OAdams, PMutations in both RAS and the PTEN/PIK3CA/AKT signaling module are found in the same human tumors. PIK3CA and AKT are downstream effectors of RAS, and the selective advantage conferred by mutation of two genes in the same pathway is unclear. Based on a comparative molecular analysis, we show that activated PIK3CA/AKT is a weaker inducer of senescence than is activated RAS. Moreover, concurrent activation of RAS and PIK3CA/AKT impairs RAS-induced senescence. In vivo, bypass of RAS-induced senescence by activated PIK3CA/AKT correlates with accelerated tumorigenesis. Thus, not all oncogenes are equally potent inducers of senescence, and, paradoxically, a weak inducer of senescence (PIK3CA/AKT) can be dominant over a strong inducer of senescence (RAS). For tumor growth, one selective advantage of concurrent mutation of RAS and PTEN/PIK3CA/AKT is suppression of RAS-induced senescence. Evidence is presented that this new understanding can be exploited in rational development and targeted application of prosenescence cancer therapies.
spellingShingle Kennedy, A
Morton, J
Manoharan, I
Nelson, D
Jamieson, N
Pawlikowski, J
McBryan, T
Doyle, B
McKay, C
Oien, K
Enders, G
Zhang, R
Sansom, O
Adams, P
Activation of the PIK3CA/AKT Pathway Suppresses Senescence Induced by an Activated RAS Oncogene to Promote Tumorigenesis
title Activation of the PIK3CA/AKT Pathway Suppresses Senescence Induced by an Activated RAS Oncogene to Promote Tumorigenesis
title_full Activation of the PIK3CA/AKT Pathway Suppresses Senescence Induced by an Activated RAS Oncogene to Promote Tumorigenesis
title_fullStr Activation of the PIK3CA/AKT Pathway Suppresses Senescence Induced by an Activated RAS Oncogene to Promote Tumorigenesis
title_full_unstemmed Activation of the PIK3CA/AKT Pathway Suppresses Senescence Induced by an Activated RAS Oncogene to Promote Tumorigenesis
title_short Activation of the PIK3CA/AKT Pathway Suppresses Senescence Induced by an Activated RAS Oncogene to Promote Tumorigenesis
title_sort activation of the pik3ca akt pathway suppresses senescence induced by an activated ras oncogene to promote tumorigenesis
work_keys_str_mv AT kennedya activationofthepik3caaktpathwaysuppressessenescenceinducedbyanactivatedrasoncogenetopromotetumorigenesis
AT mortonj activationofthepik3caaktpathwaysuppressessenescenceinducedbyanactivatedrasoncogenetopromotetumorigenesis
AT manoharani activationofthepik3caaktpathwaysuppressessenescenceinducedbyanactivatedrasoncogenetopromotetumorigenesis
AT nelsond activationofthepik3caaktpathwaysuppressessenescenceinducedbyanactivatedrasoncogenetopromotetumorigenesis
AT jamiesonn activationofthepik3caaktpathwaysuppressessenescenceinducedbyanactivatedrasoncogenetopromotetumorigenesis
AT pawlikowskij activationofthepik3caaktpathwaysuppressessenescenceinducedbyanactivatedrasoncogenetopromotetumorigenesis
AT mcbryant activationofthepik3caaktpathwaysuppressessenescenceinducedbyanactivatedrasoncogenetopromotetumorigenesis
AT doyleb activationofthepik3caaktpathwaysuppressessenescenceinducedbyanactivatedrasoncogenetopromotetumorigenesis
AT mckayc activationofthepik3caaktpathwaysuppressessenescenceinducedbyanactivatedrasoncogenetopromotetumorigenesis
AT oienk activationofthepik3caaktpathwaysuppressessenescenceinducedbyanactivatedrasoncogenetopromotetumorigenesis
AT endersg activationofthepik3caaktpathwaysuppressessenescenceinducedbyanactivatedrasoncogenetopromotetumorigenesis
AT zhangr activationofthepik3caaktpathwaysuppressessenescenceinducedbyanactivatedrasoncogenetopromotetumorigenesis
AT sansomo activationofthepik3caaktpathwaysuppressessenescenceinducedbyanactivatedrasoncogenetopromotetumorigenesis
AT adamsp activationofthepik3caaktpathwaysuppressessenescenceinducedbyanactivatedrasoncogenetopromotetumorigenesis